部分発作治療のグローバル臨床試験動向(2014年H2)...市場調査レポートについてご紹介

【英文タイトル】Partial Seizure Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Partial Seizure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Partial Seizure to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Partial Seizure to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Partial Seizure 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Partial Seizure Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
UCB S.A. 35
Clinical Trial Overview of UCB S.A. 35
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Eisai Co., Ltd. 44
Clinical Trial Overview of Eisai Co., Ltd. 44
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Johnson & Johnson 50
Clinical Trial Overview of Johnson & Johnson 50
GlaxoSmithKline plc 52
Clinical Trial Overview of GlaxoSmithKline plc 52
Bial – Portela & Ca, S.A. 54
Clinical Trial Overview of Bial – Portela & Ca, S.A. 54
SK Holdings Co., Ltd. 55
Clinical Trial Overview of SK Holdings Co., Ltd. 55
Upsher-Smith Laboratories, Inc. 56
Clinical Trial Overview of Upsher-Smith Laboratories, Inc. 56
Abbott Laboratories 57
Clinical Trial Overview of Abbott Laboratories 57
Clinical Trial Overview of Top Institutes / Government 58
National Institute of Neurological Disorders and Stroke 58
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 58
Emory University 59
Clinical Trial Overview of Emory University 59
Oregon Health & Science University 60
Clinical Trial Overview of Oregon Health & Science University 60
Kyoto University 61
Clinical Trial Overview of Kyoto University 61
National Center for Complementary and Alternative Medicine 62
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 62
Hadassah Medical Organization 63
Clinical Trial Overview of Hadassah Medical Organization 63
University of Pennsylvania 64
Clinical Trial Overview of University of Pennsylvania 64
Lawson Health Research Institute 65
Clinical Trial Overview of Lawson Health Research Institute 65
Massachusetts General Hospital 66
Clinical Trial Overview of Massachusetts General Hospital 66
University of California, Davis 67
Clinical Trial Overview of University of California, Davis 67
Five Key Clinical Profiles 68
Appendix 179
Abbreviations 179
Definitions 179
Research Methodology 180
Secondary Research 180
About GlobalData 181
Contact Us 181
Disclaimer 181
Source 181


【レポート販売概要】

■ タイトル:部分発作治療のグローバル臨床試験動向(2014年H2)
■ 英文:Partial Seizure Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月14日
■ 調査会社:GlobalData
■ 商品コード:GDHC2241CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。